National Cancer Institute Home at the National Institutes of Health | www.cancer.gov

Combining Epidemiology & Economics for Measurement of Cancer Costs Workshop Agenda

Combining Epidemiology & Economics for Measurement of Cancer Costs

Villa Mondragone, Italy
September 21 - 24, 2010

Presentations

Copies of the presentation files from this workshop are available by e-mail; please make your request to Susan Scott at scotts2@mail.nih.gov.

If you have difficulty viewing the files, please contact the ARP Web staff.


Tuesday, September 21 evening (Tenuta di Pietra Porzia)

6:00pm Arrival and Opening
Welcome to the participants
Introduction of the Workshop: Goals, Program
Dinner

Wednesday, September 22 (Villa Mondragone)

8:30am – 9:00am Registration
9:15am – 10:00am Introduction of participants

Session I: Prevalence and survival estimation

Moderator: Timo Hakulinen (Finland)
Organizer:Anna Gigli (Italy)

10:00am – 11:00am Long term survival, estimation of the proportion cured
Paul Lambert (UK)

Updating survival figures, cohort vs. period approach
Hermann Brenner (Germany)

Prevalence by time since diagnosis, complete prevalence and phases of care and recurrences, extrapolation of prevalence into the future
Angela Mariotto (USA)
11:00am – 11:30am Discussion
11:30am – 12:00noon Break

Session 2: Methods to calculate medical care cost

Moderator: Mark Hornbrook (USA)
Organizer:Robin Yabroff (USA)

12:00noon – 1:00pm What is meant by cancer costs? What is to be included?
Joseph Lipscomb (USA)

Use of administrative data to develop longitudinal costing models
Murray Krahn (Canada)
1:00pm – 2:30pm Lunch
2:30pm – 3:30pm Methods to calculate medical costs in Europe: mission impossible?
Andrea Manca (UK)

Do we take into account other costs such as lost productivity, patients’ time? Methods to calculate other costs
Jeffrey Hoch (Canada)
3:30pm – 4:00pm Break
4:00pm – 4:30pm The Italian case study
Silvia Francisci (Italy), Anna Gigli (Italy), Maura Mezzetti (Italy), Francesco Giusti (Italy), Stefano Guzzinati (Italy)
4:30pm – 5:00pm Discussion

Thursday, September 23 (Villa Mondragone)

Session 3: Cost-effectiveness, cost-benefit and decision modeling

Moderator: Eric Feuer (USA)
Organizer:Maura Mezzetti (Italy)

9:30am – 10:30am Modelling drivers of cost and benefit for policy development in cancer
Ruth Etzioni (USA)

Economic evaluation of cancer screening - case of colorectal cancer
Iris Lansdorp-Vogelaar (The Netherlands)
10:30am – 11:00am Break
11:00am – 12:00noon Using whole disease models to support the economic analysis of cancer interventions
Paul Tappenden (UK)

Economic evaluation of cancer specific targeted therapies
Isabelle Durant-Zalesky (France)
12:00noon – 12:30pm Discussion
12:30pm – 2:00pm Lunch

Session 4: Forecasting, uncertainty

Moderator: Ruth Etzioni (USA)
Organizer:Silvia Francisci (Italy)

2:00pm – 3:00pm Modifiable health behaviors and methods for analyzing changes in costs over time
Paul Fishman (USA), Mark Hornbrook (USA)

Model uncertainty in cost-effectiveness analysis
Christian Asseburg (Finland)
3:00pm – 3:30pm Break
3:30pm – 4:00pm Projections of cancer incidence and survival and corresponding costs
Robin Yabroff (USA)
4:00pm – 4:30pm Discussion

Friday, September 24 (Villa Mondragone)

Session 5: Round table: discussion topics

Moderator: Joseph Lipscomb (USA)
Organizer:Franco Berrino (Italy)

9:30am – 11:00am Data Issues: linkage of cancer registry data and administrative data – Challenges

Comparisons: US vs. Canada; fee-for-service vs. managed care
11:00am – 11:30am Break
11:30am – 1:00pm Country-specific experiences

Next steps: publication, networking for EU projects

Closing Remarks

Last Modified: 11 Apr 2014